Developer docs
API playgroundTry for free, no card

Search company profiles

Intelligent Ultrasound

Full company profile

uuid0005ooh

Namestring
Intelligent Ultrasound
Legal namestring
Intelligent Ultrasound Group PLC
Company typeenum
Public
Founded yearint
2012
Descriptiontext

Intelligent Ultrasound Group PLC was a UK-based medical technology company founded in 2012 that operated two complementary product lines: AI-powered clinical ultrasound software and a multi-specialty ultrasound simulation training portfolio. Its clinical AI software, anchored by the ScanNav Assist platform and the SonoLyst product family (SonoLystlive, SonoLyst X/IR), applied deep-learning computer vision to live obstetric ultrasound images to automatically identify, classify, and label anatomical structures in real time, and operated under FDA 21 CFR Part 11 compliance for use in regulated clinical workflows. The simulation business spanned 12+ specialty modules covering diagnostic medical sonography, OB/GYN (including endometriosis), cardiac, emergency and critical care, anesthesiology/CRNA, pediatric/neonatology, general surgery, endovascular, gastroenterology, pulmonology, orthopedic surgery, and urology, providing realistic virtual patient training for hospitals, medical schools, and MedTech customers.

The company's revenue was generated through two distinct go-to-market motions: direct enterprise sales of simulation products (hardware plus software modules) to medical schools, hospitals, simulation centers, and MedTech companies, and OEM licensing of clinical AI software embedded natively into GE HealthCare's Voluson Expert and Voluson Signature ultrasound systems. Pricing was quote-based and not publicly disclosed. Clinical AI sales reached approximately £2 million in 2023, and management concluded that clinical AI sales growth alone was insufficient to fund continued product development, which precipitated the divestiture of that segment. The simulation portfolio was distributed globally via Surgical Science's enterprise sales channels following the February 2025 acquisition.

Intelligent Ultrasound underwent a complete corporate restructuring in 2024-2025. In July 2024, GE HealthCare agreed to acquire the clinical AI software business for approximately $51 million, completing the transaction in October 2024 and absorbing the AI technology and the R&D team. On February 18, 2025, Surgical Science Sweden AB completed the purchase of the remaining Intelligent Ultrasound Group PLC entity for approximately $53 million, taking the AIM-listed company private and integrating its volumetric ultrasound simulation technology into Surgical Science's broader medical simulation portfolio. The company no longer operates as an independent entity.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersDidcot, United Kingdom
HQ citystring
Didcot
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical ultrasound simulation, AI ultrasound imaging, obstetric scanning software, sonography training systems, clinical AI imaging
Industry2 codes
1Medical Imaging AI
CodeHDAAAEAHPrimaryYes
2AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
CodeHLACALAGPrimaryNo
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Prepackaged Software7372
Product category
Medical Imaging AI Software
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Clinical AI Software Sales
TypeOne Time License
Description

Direct sales of AI-powered clinical ultrasound software (ScanNav Assist, SonoLyst family). Generated approximately £2 million in clinical AI sales in 2023. This stream was divested to GE HealthCare via the $51 million acquisition completed in Q4 2024 / October 2024.

medtechdive.com
2Medical Simulation Software & Hardware Sales
TypeOne Time License
Description

Sales of ultrasound simulation products (including volumetric ultrasound simulators) used to train sonographers, OB/GYNs, and other medical professionals across specialties. Following the February 2025 acquisition by Surgical Science, this stream is monetized within Surgical Science's broader medical simulation portfolio.

surgicalscience.com
3OEM Licensing into GE HealthCare Devices
TypeLicensing Royalties
Description

Embedded AI clinical software integrated into GE HealthCare's Voluson Expert and Voluson Signature ultrasound systems, generating per-device/per-license revenue as part of the OEM relationship.

fool.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Marketing or Sales, Operations
Pricing details1 tier
1Enterprise/B2B pricing; not publicly disclosed
ModelOther
Notes

Quote-based / Not publicly disclosed. Clinical AI products were sold via direct enterprise sales; simulation products were sold to medical schools, hospitals, and MedTech companies. GE HealthCare funded the clinical AI acquisition with cash on hand.

medtechdive.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1ScanNav Assist
Description

AI-powered image analysis technology for ultrasound devices.

finance.yahoo.com
Core offering1 text field

Intelligent Ultrasound developed and sold AI-powered clinical ultrasound image analysis software (ScanNav Assist and the SonoLyst family) that automatically identified, classified, and labeled anatomical structures during obstetric scanning in real time, and a portfolio of volumetric ultrasound simulation training systems spanning 11+ medical specialties. The clinical AI software was sold via OEM embedding into GE HealthCare ultrasound devices, while the simulation products were sold to medical schools, hospitals, and MedTech companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • £2 million in clinical AI sales (2023)
+2 more records
Product overview1 text field

Intelligent Ultrasound offers a portfolio of two complementary lines: (1) clinical AI software — ScanNav Assist and the SonoLyst product family (SonoLystlive, SonoLyst X/IR) for real-time AI-guided obstetric ultrasound scanning, which was divested to GE HealthCare for $51 million in October 2024 and is now embedded on Voluson Expert and Voluson Signature systems; and (2) a medical ultrasound simulation portfolio spanning specialty simulators for OB/GYN, Cardiac, Emergency & Critical Care, Anesthesiology/CRNA, Pediatric/Neonatology, General Surgery, Endovascular, Gastroenterology, Pulmonology, Orthopedic Surgery, Urology, and Diagnostic Medical Sonography, which was acquired by Surgical Science Sweden AB on February 18, 2025. The clinical AI line functions as an embedded software add-on to third-party ultrasound hardware, while the simulation line is a platform-plus-modules architecture where the core simulation engine supports specialty add-on modules for each clinical area.

Product and service7 records
1ScanNav Assist
CategoryClinical AI ultrasound software
Description

AI-powered real-time image analysis software that automatically identifies, classifies, and labels anatomical structures during obstetric ultrasound scanning. Designed for sonographers and obstetric clinicians; embedded on GE HealthCare's Voluson ultrasound devices following the October 2024 divestiture of the clinical AI business.

2SonoLystlive
CategoryClinical AI ultrasound software
Description

AI-powered image analysis tool that automatically recognizes and labels standard anatomical views in real time during obstetric ultrasound examinations, supporting sonographers in obtaining diagnostic-quality images.

3SonoLyst X/IR
CategoryClinical AI ultrasound software
Description

AI-driven image recognition feature for automated view classification and image quality assessment within Intelligent Ultrasound's ScanNav platform, applied to obstetric ultrasound workflows.

4Intelligent Ultrasound Simulation Platform
CategoryMedical simulation software
Description

Ultrasound simulation training platform providing realistic virtual ultrasound scanning environments for medical education across multiple specialties. Sold to medical schools, hospitals, simulation centers, and MedTech companies; now part of Surgical Science's portfolio.

5OB/GYN Ultrasound Simulator (including Endometriosis Ultrasound Simulator)
CategoryMedical simulation software
Description

Specialty ultrasound simulation module for obstetric and gynecologic ultrasound training, including the Endometriosis Ultrasound Simulator. Targeted at OB/GYN trainees and clinicians; now part of Surgical Science's simulation portfolio.

6Cardiac Ultrasound Simulator
CategoryMedical simulation software
Description

Specialty simulation module for echocardiography and cardiac ultrasound training, targeted at cardiology trainees and clinicians; now part of Surgical Science's simulation portfolio.

7Pediatric and Neonatology Ultrasound Simulator (BabyWorks)
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-04-27
Description

Cardiff-headquartered EKF Diagnostics Holdings plc completed its February 2025 acquisition of Intelligent Ultrasound Group plc and appointed Helen Jones (formerly of Surgical Science) as CFO to oversee post-acquisition integration. EKF's new CFO brings over 20 years of finance and strategic transaction experience in AIM-listed technology businesses.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-02-18
Description

Surgical Science Sweden AB completed the acquisition of Intelligent Ultrasound Group PLC on February 18, 2025, integrating Intelligent Ultrasound as a division within Surgical Science. The combination is intended to expand Surgical Science's ultrasound simulation portfolio and strengthen its UK footprint by combining Intelligent Ultrasound's volumetric ultrasound technology with Surgical Science's existing simulated ultrasound solutions.

Strategic tierFlagshipTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2024-07-19
Description

GE HealthCare acquired Intelligent Ultrasound's clinical AI software business for approximately $51 million (announced July 19, 2024; closed Q4 2024 / October 2024). The deal embeds ScanNav Assist, SonoLystlive, and SonoLyst X/IR AI image analysis into GE's Voluson Expert and Voluson Signature ultrasound devices, with GE also absorbing Intelligent Ultrasound's R&D team to accelerate AI innovation for Women's Health ultrasound devices.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AI-enabled ultrasound image guidance software for cardiac and broader diagnostic scanning. Direct peer to Intelligent Ultrasound's ScanNav clinical AI stack; notably also acquired by GE HealthCare (2023), positioning both companies within the same strategic acquirer's ultrasound AI roadmap.

TypeDirect peer
Description

Parent company and largest direct peer in medical simulation. Surgical Science's ultrasound simulation portfolio directly overlaps with Intelligent Ultrasound's volumetric ultrasound modules across multiple specialties, and the Feb 2025 acquisition made Intelligent Ultrasound a division of Surgical Science.

TypeDirect peer
Description

Major medical simulation provider with broad ultrasound simulation offerings across patient simulators, sonography training, and procedural training. Comparable to Intelligent Ultrasound's simulation portfolio across OB/GYN, emergency, and anesthesiology use cases.

TypeDirect peer
Description

Global medical simulation vendor with patient simulators and ultrasound-compatible training solutions sold to medical schools, nursing programs, and hospitals — overlapping buyer base with Intelligent Ultrasound's simulation business.

TypeBroad incumbent
Description

Acquired Intelligent Ultrasound's clinical AI business in October 2024 for $51M and is now the strategic OEM partner embedding ScanNav into Voluson. Direct incumbent in ultrasound hardware plus a growing internal ultrasound-AI portfolio (including Caption Health).

TypeEmerging player
Description

Handheld, AI-enabled point-of-care ultrasound with integrated AI guidance for imaging acquisition and interpretation. Emerging peer in the AI ultrasound workflow space targeting similar sonographer-shortage pain points as Intelligent Ultrasound's ScanNav.

TypeEmerging player
Description

AI-driven echocardiography analysis software for cardiovascular diagnostics. Emerging player in the ultrasound AI space, applying similar image-recognition techniques as Intelligent Ultrasound but specialised in cardiac use cases.

TypeEmerging player
Description

AI-guided handheld ultrasound focused on cardiac, abdominal, and procedural workflows. Emerging peer with overlapping AI ultrasound guidance capability and comparable OEM/partnership go-to-market profile.

TypeBroad incumbent
Description

Large incumbent medical imaging vendor with ultrasound systems sold globally across OB/GYN, radiology, and point-of-care. Comparable distribution profile and clinical focus as the GE HealthCare Voluson platform embedding Intelligent Ultrasound AI.

TypeEmerging player
Description

AI-based ultrasound image analysis for cardiac and abdominal imaging, sold via OEM partnerships with ultrasound vendors. Emerging peer mirroring Intelligent Ultrasound's clinical AI go-to-market approach of OEM embedding rather than direct clinical sales.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Intelligent Ultrasound

Medical Imaging AI Softwareintelligentultrasound.com

What Intelligent Ultrasound does

Intelligent Ultrasound Group PLC was a UK-based medical technology company founded in 2012 that operated two complementary product lines: AI-powered clinical ultrasound software and a multi-specialty ultrasound simulation training portfolio. Its clinical AI software, anchored by the ScanNav Assist platform and the SonoLyst product family (SonoLystlive, SonoLyst X/IR), applied deep-learning computer vision to live obstetric ultrasound images to automatically identify, classify, and label anatomical structures in real time, and operated under FDA 21 CFR Part 11 compliance for use in regulated clinical workflows. The simulation business spanned 12+ specialty modules covering diagnostic medical sonography, OB/GYN (including endometriosis), cardiac, emergency and critical care, anesthesiology/CRNA, pediatric/neonatology, general surgery, endovascular, gastroenterology, pulmonology, orthopedic surgery, and urology, providing realistic virtual patient training for hospitals, medical schools, and MedTech customers.

The company's revenue was generated through two distinct go-to-market motions: direct enterprise sales of simulation products (hardware plus software modules) to medical schools, hospitals, simulation centers, and MedTech companies, and OEM licensing of clinical AI software embedded natively into GE HealthCare's Voluson Expert and Voluson Signature ultrasound systems. Pricing was quote-based and not publicly disclosed. Clinical AI sales reached approximately £2 million in 2023, and management concluded that clinical AI sales growth alone was insufficient to fund continued product development, which precipitated the divestiture of that segment. The simulation portfolio was distributed globally via Surgical Science's enterprise sales channels following the February 2025 acquisition.

Intelligent Ultrasound underwent a complete corporate restructuring in 2024-2025. In July 2024, GE HealthCare agreed to acquire the clinical AI software business for approximately $51 million, completing the transaction in October 2024 and absorbing the AI technology and the R&D team. On February 18, 2025, Surgical Science Sweden AB completed the purchase of the remaining Intelligent Ultrasound Group PLC entity for approximately $53 million, taking the AIM-listed company private and integrating its volumetric ultrasound simulation technology into Surgical Science's broader medical simulation portfolio. The company no longer operates as an independent entity.

Intelligent Ultrasound firmographics

Firmographics
Name
Intelligent Ultrasound
Legal name
Intelligent Ultrasound Group PLC
Website
https://intelligentultrasound.com
Company type
Public
Founded year
2012
Operating status
Acquired
Headcount range
51–100 employees
Ownership category
akta.pro rank

Intelligent Ultrasound industry classification

Industry
Product category
Medical Imaging AI Software
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841), Services-Prepackaged Software (7372)
akta.pro primary industry
Medical Imaging AI (HDAAAEAH)
akta.pro secondary industry
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG)

Keywords

  • Medical ultrasound simulation
  • AI ultrasound imaging
  • Obstetric scanning software
  • Sonography training systems
  • Clinical AI imaging

Where Intelligent Ultrasound is headquartered

Location

Headquarters

HQ city
Didcot
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Intelligent Ultrasound business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

  1. Clinical AI Software Sales: Direct sales of AI-powered clinical ultrasound software (ScanNav Assist, SonoLyst family). Generated approximately £2 million in clinical AI sales in 2023. This stream was divested to GE HealthCare via the $51 million acquisition completed in Q4 2024 / October 2024.
  2. Medical Simulation Software & Hardware Sales: Sales of ultrasound simulation products (including volumetric ultrasound simulators) used to train sonographers, OB/GYNs, and other medical professionals across specialties. Following the February 2025 acquisition by Surgical Science, this stream is monetized within Surgical Science's broader medical simulation portfolio.
  3. OEM Licensing into GE HealthCare Devices: Embedded AI clinical software integrated into GE HealthCare's Voluson Expert and Voluson Signature ultrasound systems, generating per-device/per-license revenue as part of the OEM relationship.

Pricing tiers

ModelBillingPrice
Other—Enterprise/B2B pricing; not publicly disclosed

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Intelligent Ultrasound product offering

Product offering

Core offering

Intelligent Ultrasound developed and sold AI-powered clinical ultrasound image analysis software (ScanNav Assist and the SonoLyst family) that automatically identified, classified, and labeled anatomical structures during obstetric scanning in real time, and a portfolio of volumetric ultrasound simulation training systems spanning 11+ medical specialties. The clinical AI software was sold via OEM embedding into GE HealthCare ultrasound devices, while the simulation products were sold to medical schools, hospitals, and MedTech companies.

Product overview

Intelligent Ultrasound offers a portfolio of two complementary lines: (1) clinical AI software — ScanNav Assist and the SonoLyst product family (SonoLystlive, SonoLyst X/IR) for real-time AI-guided obstetric ultrasound scanning, which was divested to GE HealthCare for $51 million in October 2024 and is now embedded on Voluson Expert and Voluson Signature systems; and (2) a medical ultrasound simulation portfolio spanning specialty simulators for OB/GYN, Cardiac, Emergency & Critical Care, Anesthesiology/CRNA, Pediatric/Neonatology, General Surgery, Endovascular, Gastroenterology, Pulmonology, Orthopedic Surgery, Urology, and Diagnostic Medical Sonography, which was acquired by Surgical Science Sweden AB on February 18, 2025. The clinical AI line functions as an embedded software add-on to third-party ultrasound hardware, while the simulation line is a platform-plus-modules architecture where the core simulation engine supports specialty add-on modules for each clinical area.

Differentiator

Problem solved

Functional benefit

Brands

  • ScanNav Assist: AI-powered image analysis technology for ultrasound devices.

Products and services

  • ScanNav Assist AI-powered real-time image analysis software that automatically identifies, classifies, and labels anatomical structures during obstetric ultrasound scanning. Designed for sonographers and obstetric clinicians; embedded on GE HealthCare's Voluson ultrasound devices following the October 2024 divestiture of the clinical AI business.
  • SonoLystlive AI-powered image analysis tool that automatically recognizes and labels standard anatomical views in real time during obstetric ultrasound examinations, supporting sonographers in obtaining diagnostic-quality images.
  • SonoLyst X/IR AI-driven image recognition feature for automated view classification and image quality assessment within Intelligent Ultrasound's ScanNav platform, applied to obstetric ultrasound workflows.
  • Intelligent Ultrasound Simulation Platform Ultrasound simulation training platform providing realistic virtual ultrasound scanning environments for medical education across multiple specialties. Sold to medical schools, hospitals, simulation centers, and MedTech companies; now part of Surgical Science's portfolio.
  • OB/GYN Ultrasound Simulator (including Endometriosis Ultrasound Simulator) Specialty ultrasound simulation module for obstetric and gynecologic ultrasound training, including the Endometriosis Ultrasound Simulator. Targeted at OB/GYN trainees and clinicians; now part of Surgical Science's simulation portfolio.
  • Cardiac Ultrasound Simulator Specialty simulation module for echocardiography and cardiac ultrasound training, targeted at cardiology trainees and clinicians; now part of Surgical Science's simulation portfolio.
  • Pediatric and Neonatology Ultrasound Simulator (BabyWorks)

Quantifiable outcome

  • £2 million in clinical AI sales (2023)
  • +2 more outcomes

Companies that use Intelligent Ultrasound

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Intelligent Ultrasound technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature5 records

Intelligent Ultrasound partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered minor and flagship.

  • EKF Diagnostics Holdings plcminorStrategic or Co-development Partner · 27 April 2026Cardiff-headquartered EKF Diagnostics Holdings plc completed its February 2025 acquisition of Intelligent Ultrasound Group plc and appointed Helen Jones (formerly of Surgical Science) as CFO to oversee post-acquisition integration. EKF's new CFO brings over 20 years of finance and strategic transaction experience in AIM-listed technology businesses.
  • Surgical Science Sweden ABflagshipStrategic or Co-development Partner · 18 February 2025Surgical Science Sweden AB completed the acquisition of Intelligent Ultrasound Group PLC on February 18, 2025, integrating Intelligent Ultrasound as a division within Surgical Science. The combination is intended to expand Surgical Science's ultrasound simulation portfolio and strengthen its UK footprint by combining Intelligent Ultrasound's volumetric ultrasound technology with Surgical Science's existing simulated ultrasound solutions.
  • GE HealthCare Technologies Inc.flagshipOEM/ Whitelabel/ Licensing Partner · 19 July 2024GE HealthCare acquired Intelligent Ultrasound's clinical AI software business for approximately $51 million (announced July 19, 2024; closed Q4 2024 / October 2024). The deal embeds ScanNav Assist, SonoLystlive, and SonoLyst X/IR AI image analysis into GE's Voluson Expert and Voluson Signature ultrasound devices, with GE also absorbing Intelligent Ultrasound's R&D team to accelerate AI innovation for Women's Health ultrasound devices.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Intelligent Ultrasound competitors and assessment

Company assessment

Direct peers

  • Caption Health: AI-enabled ultrasound image guidance software for cardiac and broader diagnostic scanning. Direct peer to Intelligent Ultrasound's ScanNav clinical AI stack; notably also acquired by GE HealthCare (2023), positioning both companies within the same strategic acquirer's ultrasound AI roadmap.
  • Surgical Science Sweden AB: Parent company and largest direct peer in medical simulation. Surgical Science's ultrasound simulation portfolio directly overlaps with Intelligent Ultrasound's volumetric ultrasound modules across multiple specialties, and the Feb 2025 acquisition made Intelligent Ultrasound a division of Surgical Science.
  • CAE Healthcare: Major medical simulation provider with broad ultrasound simulation offerings across patient simulators, sonography training, and procedural training. Comparable to Intelligent Ultrasound's simulation portfolio across OB/GYN, emergency, and anesthesiology use cases.
  • Laerdal Medical: Global medical simulation vendor with patient simulators and ultrasound-compatible training solutions sold to medical schools, nursing programs, and hospitals — overlapping buyer base with Intelligent Ultrasound's simulation business.

Broad incumbents

  • GE HealthCare: Acquired Intelligent Ultrasound's clinical AI business in October 2024 for $51M and is now the strategic OEM partner embedding ScanNav into Voluson. Direct incumbent in ultrasound hardware plus a growing internal ultrasound-AI portfolio (including Caption Health).
  • Mindray: Large incumbent medical imaging vendor with ultrasound systems sold globally across OB/GYN, radiology, and point-of-care. Comparable distribution profile and clinical focus as the GE HealthCare Voluson platform embedding Intelligent Ultrasound AI.

Emerging players

  • Butterfly Network: Handheld, AI-enabled point-of-care ultrasound with integrated AI guidance for imaging acquisition and interpretation. Emerging peer in the AI ultrasound workflow space targeting similar sonographer-shortage pain points as Intelligent Ultrasound's ScanNav.
  • Ultromics: AI-driven echocardiography analysis software for cardiovascular diagnostics. Emerging player in the ultrasound AI space, applying similar image-recognition techniques as Intelligent Ultrasound but specialised in cardiac use cases.
  • EchoNous: AI-guided handheld ultrasound focused on cardiac, abdominal, and procedural workflows. Emerging peer with overlapping AI ultrasound guidance capability and comparable OEM/partnership go-to-market profile.
  • DiA Imaging Analysis: AI-based ultrasound image analysis for cardiac and abdominal imaging, sold via OEM partnerships with ultrasound vendors. Emerging peer mirroring Intelligent Ultrasound's clinical AI go-to-market approach of OEM embedding rather than direct clinical sales.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Intelligent Ultrasound social profiles

Digital presence

Intelligent Ultrasound compliance and trust

Trust signal

Compliance1 record

Intelligent Ultrasound financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Intelligent Ultrasound leadership team

Management profile

Number of profiles

Profiles5 records

Intelligent Ultrasound funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Intelligent Ultrasound M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Intelligent Ultrasound

What does Intelligent Ultrasound do?

Intelligent Ultrasound developed and sold AI-powered clinical ultrasound image analysis software (ScanNav Assist and the SonoLyst family) that automatically identified, classified, and labeled anatomical structures during obstetric scanning in real time, and a portfolio of volumetric ultrasound simulation training systems spanning 11+ medical specialties. The clinical AI software was sold via OEM embedding into GE HealthCare ultrasound devices, while the simulation products were sold to medical schools, hospitals, and MedTech companies.

Is Intelligent Ultrasound a public or private company?

Intelligent Ultrasound is a public company. It is classified as corporate owned and is currently acquired.

When was Intelligent Ultrasound founded?

Intelligent Ultrasound was founded in 2012. It employs 51 to 100 people.

Where is Intelligent Ultrasound based?

Intelligent Ultrasound is headquartered in Didcot, United Kingdom, in the Europe region.

How does Intelligent Ultrasound make money?

Three revenue lines are on record. Clinical AI Software Sales are the primary driver. The others are medical Simulation Software & Hardware Sales and OEM Licensing into GE HealthCare Devices.

Who are Intelligent Ultrasound's main competitors?

Direct peers on record are Caption Health, Surgical Science Sweden AB, CAE Healthcare and Laerdal Medical. Broad incumbents are GE HealthCare and Mindray. Emerging players are Butterfly Network, Ultromics, EchoNous and DiA Imaging Analysis.

Does Intelligent Ultrasound have an API?

No public API is recorded for Intelligent Ultrasound.

What industry is Intelligent Ultrasound in?

Intelligent Ultrasound's product category is Medical Imaging AI Software. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Medical BuyerUltrasound-on-chip licensing market to reach USD 200.5MThe ultrasound-on-chip licensing market is projected to grow from USD 43.5 million in 2025 to USD 200.5 million by 2036, representing a compound annual growth rate of 14.9%, with Butterfly Embedded estimated to hold a 61% share of the technology provider segment. The medical sector is expected to dominate application areas at 72% share in 2026, driven by regulatory familiarity and the ability to offer validated paths from chip behavior to clinical output. AI integration is shifting ultrasound value toward acquisition guidance and workflow software, exemplified by GE HealthCare's acquisition of Intelligent Ultrasound's clinical AI business for approximately USD 51 million.openPR.comGlobal Trends Analysis: The Rapid Evolution of the AI Medical Diagnostics MarketThe AI in medical diagnostics market is projected to reach $14.03 billion by 2030, growing at a compound annual growth rate of 38.7%, driven by AI-powered imaging adoption, demand for faster diagnostics, and precision medicine advancements. In October 2024, GE HealthCare Technologies Inc. acquired Intelligent Ultrasound Group PLC for approximately $53 million to integrate AI-driven ultrasound tools into its portfolio. In November 2024, UAE-based Forte Healthcare launched MediBAY, an AI-powered clinic model enabling patients to complete healthcare visits within 30 minutes using digital pods and tele-consultations.InsidermediaEKF appoints highly-experienced chief financial officer - has led finance, operations and strategic transactions in high-growth, technology-driven AIM listed businessesCardiff-headquartered EKF Diagnostics Holdings plc has appointed Helen Jones as its new Chief Financial Officer, effective immediately, succeeding Stephen Young who is retiring. Jones joins from Surgical Science with over 20 years of experience in finance, operations, and strategic transactions within AIM-listed technology-driven businesses. She will oversee post-acquisition integration following EKF's February 2025 acquisition of Intelligent Ultrasound Group plc as the company executes its five-year development plan for accelerated growth.openPR.comEmerging Growth Patterns Driving Expansion in the Ultrasonic Technology MarketThe global ultrasonic technology market is projected to grow from its current size to $5.32 billion by 2030, representing a compound annual growth rate of 15.3%, driven by smart manufacturing adoption, medical imaging demand, autonomous vehicle sensing, and IoT integration. In July 2024, GE HealthCare Technologies Inc. acquired the clinical artificial intelligence software business from UK-based Intelligent Ultrasound Group PLC for $51 million to strengthen its diagnostic precision and efficiency capabilities. In February 2024, Japan-based Fujifilm introduced the ALOKA ARIETTA 850 Diagnostic Ultrasound System at Fortis Hospital in Bengaluru, marking a new product launch for gastrointestinal diagnostics and cancer staging.YahooGlobal Portable Ultrasound Market to Reach USD 3.83 Billion by 2030 | MarketsandMarkets™The global portable ultrasound market is projected to grow from USD 2.49 billion in 2025 to USD 3.84 billion by 2030, representing a 9.0% compound annual growth rate, driven by chronic disease prevalence, AI integration, and telemedicine adoption. GE HealthCare maintains market leadership with an estimated 20-25% share, followed by Philips Healthcare at 15-20% and Siemens Healthineers at 8-10%, with consolidation occurring through acquisitions such as GE Healthcare's purchase of Intelligent Ultrasound Group Plc. The Asia-Pacific region is emerging as the fastest-growing market due to aging populations in Japan, South Korea, and China, along with expanding government healthcare investment in rural areas.openPR.comSegmentation Analysis, Market Trends, and Competitive Landscape in the Image Guided Surgery Devices MarketThe article discusses the growth and developments in the image guided surgery devices market, which is expected to reach $17.85 billion by 2030 with a CAGR of 13.0%. It highlights key companies, trends, and recent acquisitions, including GE Healthcare's purchase of Intelligent Ultrasound Group.Coherent Market InsightsArtificial Intelligence Diagnostics Market Size & Share,2033The global AI diagnostics market is projected to grow from USD 2,680.3 million in 2026 to USD 10,416.2 million by 2033, with a compound annual growth rate of 21.4%, driven by increasing demand for precision medicine and integration of AI into healthcare systems. In July 2024, GE HealthCare acquired the clinical AI software business of Intelligent Ultrasound Group for approximately $51 million to strengthen its AI-enabled ultrasound imaging capabilities, while other key players including Siemens Healthineers and Qure.AI made significant AI integration advancements in 2024. North America currently holds a dominant 40.1% market share, supported by high investments in healthcare technology and FDA regulatory advancements.openPR.comUltrasound AI Market Growth: Opportunities Across HealthcareMarketsandMarkets released a market research report forecasting the global ultrasound AI market to grow from USD 2.35 billion in 2025 to USD 6.88 billion by 2030, representing a compound annual growth rate of 24.0%, with North America accounting for the largest market share driven by rapid adoption of portable ultrasound devices and high healthcare expenditure. Key recent developments include GE HealthCare's July 2024 acquisition of UK-based Intelligent Ultrasound Group Plc for workflow enhancement, and GE HealthCare's March 2025 collaboration with NVIDIA to develop AI-powered imaging systems using NVIDIA's Isaac for Healthcare platform. Additional market activities include Hologic's divestiture of its SSI ultrasound imaging business to SSH Holdings Limited for USD 1.9 million and Canon's creation of a new US subsidiary, Canon Healthcare USA Inc., signaling expanded competition in the medical imaging sector.FortunebusinessinsightsHealthcare Simulation Market Size, ShareThe global healthcare simulation market is projected to grow from USD 2.41 billion in 2026 to USD 5.00 billion by 2034, representing a compound annual growth rate of 9.6%, driven by rising focus on patient safety, increasing surgical volumes, and the shift toward digital and AR/VR simulation platforms. North America dominated the market with a 37.15% share in 2025, while Asia Pacific and Latin America present significant growth opportunities as medical education infrastructure expands in emerging economies. Strategic partnerships and acquisitions, including Surgical Science's purchase of Intelligent Ultrasound Group and Elevate Healthcare's VR collaboration with SimX, are reshaping the competitive landscape.VmrHealthcare Simulators Market Size, Share, Trends & Growth Forecast 2035The global Healthcare Simulators Market is projected to grow from USD 3.24 billion in 2025 to USD 12.65 billion by 2035, representing a compound annual growth rate of 14.6%, driven by regulatory mandates for patient safety, technological advances in high-fidelity simulation, and the global shortage of healthcare professionals. North America held the largest market share at over 38% in 2025, while Asia Pacific exhibits the fastest growth due to rapid expansion of private medical schools in China and India. Recent company developments include Surgical Science Sweden AB's acquisition of Intelligent Ultrasound's simulation business, Elevate Healthcare's launch of the EVO modular patient simulation platform, and Laerdal Global Health's deployment of nearly 900 birthing simulators across 13 African countries.